Skip to main content
OpenTrials

Clinical trial condition

Metastatic Colorectal Cancer

Explore clinical trials studying Metastatic Colorectal Cancer. Study availability and eligibility vary by location and protocol.

386 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Colorectal Cancer trial results

Completed

Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment

NCT04826003

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Rigshospitalet København Ø, Denmark
  • NKI/AvL Amsterdam, Netherlands
  • Severance Hospital, Yonsei University Health System Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
View all 13 locations
View Trial Details
Completed

FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

NCT03584711

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Clinique Trenel Sainte-Colombe, Lyon, France
  • Clinique Claude Bernard Albi, France
  • Clinique Claude Bernard Albi, France
  • Hopital Sud Amiens, France
View all 124 locations
View Trial Details
Completed

Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer

NCT03186326

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • Ch - Centre Hospitalier D'Abbeville Abbeville, France
  • Ch - Centre Hospitalier Du Pays D'Aix Aix-en-Provence, France
  • Chu - Hôpital Sud - Service D'Hge Amiens, France
  • Privé - Clinique de L'Europe Amiens, France
View all 120 locations
View Trial Details
Completed

MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)

NCT04495621

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • The Oncology Institute of Hope and Innovation Anaheim, California, United States
  • MultiCare Health System Institute for Research and Innovation Tacoma, Washington, United States
  • ICO - Site Paul Papin Angers, France
View all 28 locations
View Trial Details
Completed

A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

NCT04322539

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC-HOPE Tucson, Arizona, United States
  • California Research Institute (CRI) Los Angeles, California, United States
  • City of Hope Comprehensive Cancer Center Los Angeles, California, United States
View all 153 locations
View Trial Details
Completed

Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation

NCT03829410

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
View Trial Details

Related conditions